Conferences and Meetings 703. Cellular Immunotherapies other than CAR-T Cells: Poster III

703. Cellular Immunotherapies other than CAR-T Cells: Poster III

Category: Conferences and Meetings

Short name: updated-703. Cellular Immunotherapies other than CAR-T Cells: Poster III-2025 Annual Meeting Poster Bundle Immune Regulation & Therapies

Course start date: 02/17/2026

Sections

Lipid nanoparticle mediated mRNA transfection enables efficient and safe generation of CAR macrophages

Reactivating mutant p53 in T cells enhances anti tumor activity in Acute Myeloid Leukemia

Engineered iPSC derived NK cells targeting the SIGLEC7 glyco immune checkpoint improves anti tumor activity in solid cancers

Long term outcomes of double negative T cell therapy in AML patients with relapse post allo HSCT

Development of ALK directed TCR T cells with potent and specific anti tumor activity against ALK positive anaplastic large cell lymphoma

Scalable production and anti tumor efficacy of iPSC derived immortalized anti CD19 CAR macrophages

Development of a CAR NK therapy regulated by the KLRC1 locus as a new platform for selective control of acute myeloid leukaemia